- Story /
Novartis is taming nuclear power and putting it to use to treat advanced cancer.
- Story /
Technology used to tag friends on social media could change the way drug discovery is done.
- Story /
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
- Story /
The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
- Story /
Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
- Story /
Novartis researchers aim to preserve kidney function – and quality of life – for patients.
- Story /
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
- Story /
Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.
- Story /
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
- Story /
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
Pagination
- ‹ Previous page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- …
- 38
- › Next page